We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Next-Generation Total Artificial Heart System to Be Presented at IEEE EMBC 2026

By HospiMedica International staff writers
Posted on 28 Jul 2026

End-stage heart failure remains a major driver of morbidity and mortality, and some patients continue to decline while awaiting heart transplantation. More...

When conventional mechanical circulatory support is inadequate, total artificial hearts can provide full biventricular replacement. Ongoing engineering advances are focused on improving reliability, power management, and patient mobility. A new system will be presented that combines established artificial heart ventricles with a next-generation electromechanical drive to advance mechanical circulatory support.

Picard Medical Inc., parent company of SynCardia Systems LLC, announced that The Emperor Total Artificial Heart (Emperor TAH) will be introduced to the biomedical engineering community at the 48th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 2026), held July 26–30, 2026, in Toronto, Canada. The appearance marks the first public scientific presentation of the Emperor Drive System (EDS) architecture.

The work will be presented as a poster on Wednesday, July 29, 2026, from 4:30 PM to 6:30 PM EDT in Hall E as part of “Theme 6: Wearable Biomedical Sensors and Systems.” The poster is titled “The Emperor Total Artificial Heart: A Preliminary Electromechanical Architecture for a Total Artificial Heart.”

The Emperor TAH is designed to pair the proven SynCardia Total Artificial Heart (STAH) ventricles with the next-generation electromechanical Emperor Drive System. The poster will outline the preliminary electromechanical architecture of the EDS and its integration with the STAH ventricles. In clinical application, the STAH assumes the full functions of a failing or failed human heart, and the EDS is intended to provide the electromechanical actuation required for sustained mechanical circulatory support.

The STAH is the first artificial heart approved by the U.S. Food and Drug Administration (FDA) and Health Canada and remains the only commercially available artificial heart in the United States and Canada. More than 2,100 implants have been performed at hospitals across 27 countries, making it the most widely used and extensively studied artificial heart platform to date. Additional technical details on the Emperor TAH architecture are expected to follow the conference presentation.

“IEEE EMBC represents an important opportunity to share the progress our team has made in advancing total artificial heart technology. The Emperor Drive System builds upon decades of SynCardia experience while incorporating new engineering approaches designed to advance the continued evolution of mechanical circulatory support,” said Taha Hasekioglu, Director, Office of the COO & Emperor Program Lead.

Related Links
SynCardia System
Picard Medical
EMBC 2026


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Brain PET imaging could help identify Alzheimer’s patients most likely to benefit from available therapies (Image Credit: iStock)

Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy

Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.